ThermoGenesis Reports Q2 EPS of $0.03 vs. $0.01

ThermoGenesis Corp. KOOL reported results for the second quarter of fiscal 2011. For the quarter ended December 31, 2010, the Company reported revenues of $5.9 million, which compares with revenues of $6.0 million in the second quarter a year ago. Disposable revenues in the second quarter of fiscal 2011 were $3.4 million compared to $3.5 million in the same period a year ago. ThermoGenesis reported a net loss of $486,000, or $0.03 per share, for the second quarter of 2011, versus a net loss of $1.5 million, or $0.10 per share, in the same period a year ago. Included in the Company's results for the second quarter of 2011 are $200,000 in strategic advisory fees and approximately $100,000 in non-cash, stock-based compensation expenses attributable to restricted stock related to a distribution agreement with Nanshan Memorial Medical Institute (“Nanshan”). ThermoGenesis ended the second quarter of 2011 with $10.2 million in cash and cash equivalents. This is approximately the same cash balance as in the prior quarter and compares with a balance of $10.7 million at the end of fiscal 2010. Backlog at the end of the second quarter of 2011 was approximately $750,000.